Mimecan
| GO Term | Evidence Code | Reference |
|---|---|---|
| negative regulation of smooth muscle cell proliferation | ||
| bone development | ||
| articular cartilage development |
| GO Term | Evidence Code | Reference |
|---|---|---|
| extracellular region | ||
| extracellular region | ||
| obsolete extracellular space |
|
|
| Golgi lumen | ||
| extracellular matrix |
| GO Term | Evidence Code | Reference |
|---|---|---|
| growth factor activity |
|
|
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 80 |
|
|||
| 88 |
|
|
||
| 214 |
|
|
||
| 258 |
|
| Pathway Name | Organism |
|---|---|
| Defective B4GALT1 causes B4GALT1-CDG (CDG-2d) | Homo sapiens |
| Defective CHST6 causes MCDC1 | Homo sapiens |
| Defective ST3GAL3 causes MCT12 and EIEE15 | Homo sapiens |
| Keratan sulfate biosynthesis | Homo sapiens |
| Keratan sulfate degradation | Homo sapiens |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026